🔗 Visit the ClinicalTrials.gov page for NCT01312376
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Dendritic cell-based interventions for cancer therapy. | Oncoimmunology | 2012 | 1.51 |
| 2 | Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer. | Oncoimmunology | 2013 | 1.37 |
| 3 | Trial Watch: Adoptive cell transfer immunotherapy. | Oncoimmunology | 2012 | 1.18 |
| 4 | Immunotherapeutic approaches to ovarian cancer treatment. | J Immunother Cancer | 2015 | 0.88 |
| 5 | Past, present and future targets for immunotherapy in ovarian cancer. | Immunotherapy | 2014 | 0.87 |
| 6 | Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. | Oncoimmunology | 2016 | 0.84 |
| 7 | Targeting CD8+ T-cell tolerance for cancer immunotherapy. | Immunotherapy | 2014 | 0.81 |
| 8 | Adoptive immunotherapy against ovarian cancer. | J Ovarian Res | 2016 | 0.79 |